chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It was just that I got Covid, congestion, sore throat, slight cough, horrible headache. I'm still having symptom and I'm on day 14 from testing positive. They have been minor.
Large welt which patient measured to be 3 inches long and 2 inches wide.  Located at injection site of shingles vaccine on left arm that she received on 04/21/15. Patient states that it looks like a large hive. It is not itchy and no red streaks noted. Patient is not sure when this developed but she first noticed it about 0930 today.
DIZZNESS/ BPV STARTED ONE DAY AFTER VACCINATION REQUIRING HOSPITALIZATION. WAS DIAGNOSED WITH BPV.
Received Hep A #1 on Thursday Sept 14th 2006, Friday am mother noticed rash at site of injection papular, raised multiple lesion right deltoid.
heart palpitations faster than normal; right now he is notfeeling that bad compared to a couple of days after the vaccine; heart palpitation; This is a spontaneous report from a contactable consumer (patient).   A 50-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: ER2613), via an unspecified route of administration, administered in Arm Left on 26Mar2021 14:45 as dose 1, single for covid-19 immunisation. The patient medical history was none. The patient concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient experienced heart palpitations faster than normal, right now he is not feeling that bad compared to a couple of days after the vaccine, and heart palpitation on an unknown date. Caller stated he has the heart question after he got the Pfizer Vaccine but and right now he is not feeling that bad compared to a couple of days after the vaccine and as the day goes it is better and better and did not have to go to the hospital and nothing was needed, stated what is going on he is healthy overall and not taking any kind of medication, is 52 years old and has a healthy lifestyle, stated for 3 days he had that happen with his heart bumping but not much of an issue and he is feeling better. Stated he looked up online the reaction he had which was heart palpitation being faster than normal and looked it up on the Pfizer website about this concern and he had no other symptoms and the heart palpitations and asks if that is normal. The patient underwent lab tests and procedures, which includes Nasal swab, SARS CoV 2 Test: Negative on 31Mar2021. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
Within 24 hours of taking my 2nd dose Covid Vaccine (Pfizer), I started itching ALL over - An INTENSE never had it before itch!!! I was also burning! My head, feet, even groin.....just itching ALL over with no breathing issues or rashes, but skin did become inflamed from me scratching. I tool one dose of Behedryl and increased Allegra to once per day; a few weeks later after my condition got worse, went to the doctor  and was prescribed a steroid pack and 25 mg of hydroxyzine, along with a referral to see a skin allergist! Tomorrow I will finally see the Skin Allergist!!! I couldn't fo before due to me not being able to stay off an antihistmine for 72 hours. I am hoping that one day I won't have to take antihistamines, but for now, they provide much relief to this rare side effect that I NEVER experienced prior to my 2nd Covid Vacine.
Normal side effects followed by severe menstrual cramps, heavy bleeding, period lasting two weeks. Typically my period s are fairly light, my cramps are bearable, and it lasts 5 days tops. The pain was so severe I couldn?t get out of bed. It would cause me to dry heave. I couldn?t eat I couldn?t sleep. It made me cry. The amount I usually bleed I can comfortably wear tampons or a menstrual cup an have no concerns about leaking. Tampons weren?t an option. They would be useless within a half hour. My menstrual cup that is supposed to be able to be left in for up to 12 hour and holds an ounce was having to be emptied every hour because it was overflowing. I had to wear the heaviest duty night time pads I could find and still I was changing them extremely often. My following periods since have been the same. Then I completely missed a period when I?m very regular. And the period following that I had to call my doctor because I was in too much pain to handle. During this time I?ve had no out of the ordinary stress and I?m my entire life I?ve never had anything that has ever triggered a period like the ones I?ve had since getting vaccinated.
t99-100, congestion, swollen, mattery eyes 2-3 days prior to becoming non-responsive; taken to hosp & given oxygen, suctioned & breathing tx; given antibiotic, IV fluids, & APAP suppositories;
Incorrect booster dose given. Patient received received 0.5ml of Moderna another 0.75ml booster dose.
Shortness of breath, chills, heat flashes, Body aches, headache, sharp leg pain, sharp arm pain, muscle aches, chest pain, joint pain, ear throbbing in left ear, ringing in right ear, fatigue, dizziness.
onset of bilateral rash on palms 3 days after vaccination.  rash was macular and spotted erythema.  described as itchy. resolved after 5 days
Progressive constellation of symptoms including abdominal pain, vomiting and MRI findings of cerebellitis.
On 10/5/03-had seizure somewhat prolonged. Associated with fever. This was 8 day after vaccination with MMR and Varivax. I have no way of knowing if events related.
Axillary temp to 102.3 F 1 1/2 hrs after 1st set of immunizations. Re-examined 6 hours after immunization. No apparent source for fever. She was admitted for overnight observation. Vomiting x 1. Diarrhea on two occasions after admission. Blood/urine and stool studies - negative. 7/2/08-records received for DOS 4/22/08-DX:Fever without a source. Hour after immunizations spike a temperature to 102.3. Admitted overnight for observation.
Vaccine had expired 06302021. It had been taken out of refrigerator and at some point replace back in refrigerator .  I do not know how long it had been  exposed to heat/light.  Vaccinator did not look at the date until after it was given.  Patient did not experience  any adverse reactions.
After receiving flu shot in Sept 2018, I developed guillan barre type symptoms which lasted 2 month. Also have had a painful lump and shoulder pain/ Immobility in left arm
was given the flu shot in thr right shoulder the shot was very painful arm bled and I got a huge lump> by 4:00  mu body hurt all over from ankles to head< it was a deep inner pain effecting my mmuscles. had a hard time walking to my car got home and managed to lay on the couch for a few hours then struggled to get up to use the bathroom, my head felt like it would blow up> it continue all weekend until I took an Oxycodone which relieved the pain and was able to move more freely< the whole shoulder was bruised and still it>
This spontaneous case, initially received on 02-Nov-2016, was reported by a health professional and concerns a 78 year old patient. Weight: not provided; Height: not provided. Concomitant medication: Not reported. Administration of company suspect drug(s): On 16-Sep-2016 the patient received AFLURIA. Dose regimen: Not reported, Route of administration: Intramuscular. Batch number: WT54306. No additional suspect drugs. Adverse event description: On 23-Sep-2016, a nurse reported that a refrigerator went in and out of (temperature) range while there was flu vaccine in it. On 16-Sep-2016, doses were administered (special circumstances: drug administration error without adverse event, incorrect product storage without adverse event). Flu vaccine was first delivered to the vaccination facility on 15-Aug-2016. As the nurse reviewed the refrigerator temperature log, she stated that another excursion occurred on 15-Sep-2016. The doses arrived at 09:00 and were placed in a refrigerator that was 10 degrees Celsius in the morning. Then the temperature remained at 9 degrees Celsius throughout the 15th and 51 doses were administered on the 16th at a flu clinic. The refrigerator was not back in range until 19-sep-2016 at a temperature of 8 degrees Celsius. Temperature excursion identified: Log documentation reflected temperature excursions from 31-May-2016 to 23-Sep-2016 which ranged between 8 to 10 degrees Celsius. Vaccines had been given to patients between 31-May-2016 and 23-Sep-2016. On 04-Oct-2016, the remaining 42 doses of lot number WT54306 were discarded. The patients will be contacted for revaccination.
The pt experienced hives, itching over much of upper body. Self-treated with Benadryl.
This spontaneous report as received from a pharmacist, who is also a patient's mother, refers to a currently 11-year-old female patient. The patient did not have any pertinent medical history, drug reactions or allergies and concomitant therapies. On an unknown date in November 2017, the patient was vaccinated with the first dose of GARDASIL 9 intramuscular (dose, lot# and expiration date were not reported) for prevention of HPV. On an unknown date (reported as 48 hours after the vaccination), the patient developed erythema, swelling and pain at the injection site. The patient was given ibuprofen for the adverse events. The patient did not seek medical attention and her physician was unaware of the adverse effects. The events of erythema, swelling and pain at the injection site resolved after 3 days. The relatedness between the events and vaccination with GARDASIL 9 was not reported.
Hardness at the injection site; Swelling at the injection site; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE PAIN (Pain at the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 31-Mar-2021, the patient experienced VACCINATION SITE INDURATION (Hardness at the injection site) and VACCINATION SITE SWELLING (Swelling at the injection site). At the time of the report, VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE PAIN (Pain at the injection site) outcome was unknown.            Concomitant medications were not reported.  No treatment information was specified.
My blood pressure went high - 163/87. This happened on 3/5/2021 and 3/6/2021.
patient started complaining of leg cramps and went back to his room, then left arm pain and body pain was given some nitro, patient vomited and a headache
I had my vaccination on 09/09/2022. The next day on 09/10/2022 I was doing my Benign Vertigo positioning exercises the Brandt-Daroff. On the first set I had an overwhelming sensation of extreme of the wall moving at very fast speeds. I usually get vertigo that goes away after a few seconds but this was completely different. I had physical therapy later that day to work on balance issues. My vertigo was present in the stigmatism in my eyes and we worked on the Epley maneuver. I had a little bit of Vertigo on the 09/11/2022. I am better today on 09/13/2022 with residual vertigo left.
Developed a blood clot in pinky, went to ER and triage PA said it was a superficial venous thrombosis and nothing to worry about. Discharged home with no blood work.
Pt c/o "wad of snot in throat." Denies itching or swelling of throat. Reporting coughing up scant amount of mucous. Provided cold water, with relief. Pt also able to procure cough drop from purse, with further relief of symptoms. Tolerating water without difficulty, no difficulty swallowing. VSS. No s/s of distress noted. VS are as follows: 1240: BP 128/58, HR 100, RR 16, O2 sat 100% on RA 1242: BP 125/84, HR 79, RR 16, O2 sat 100% on RA 1245: BP 137/85, HR 85, RR 16, O2 sat 97% on RA
Vaginal bleeding/spotting for four days beginning 11/07/2021 - 11/10/2021
Skin turned yellow, diarrhea with blood, vomiting, red blood count dropped taking off formula of 5 wks, blood transfusion, white blood count down, given antibiotics, fluids, probiotics, kidneys, spleen and liver enlarged. Patient, was a ECMO patient at hospital. He was born with pulmonary hypertension, heart murmur, enlarged spleen and liver. He also swallowed the amnio fluid and his lungs were compromised so he became a ECMO patient. Was on ECMO 2-3-14 thru 2-10-14. He has been on feeding tube since 2-3-14. Patient was recovering from these illnesses. His liver and spleen were back to normal as of 2-26-14. Took off oxygen on 2-26-14. Started breast feeding with improvement each day. Doctor was going to release him to go home. On March 4 administered Hep B vac. March 5th had vomiting, bloody stools, skin yellowing, started losing weight, took off milk. Liver and spleen enlarged again, kidneys enlarged secreting protein in kidneys, had low red blood cells blood transfusion, put back on oxygen very raspy breathing, low white blood cells gave antibiotics. Since the Hep B vaccine he relapsed back at least 2 wks or more wks. As of 4-21-14 is still in hospital.
Employee's mother tested positive for COVID, so she did a rapid home test and tested positive.  Asymptomatic
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. Concurrent condition and medical history of the patients were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB (lot # reported as L051125, expiration date: 14-OCT-2018; lot# reported as M006710, expiration date: 06-DEC-2018) (dose and route unspecified). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Patient tested positive for COVID-19 after completing the full Moderna vaccine series, 50 days after 2nd dose.   Patient received 2nd dose of COVID vaccine on 1/27/21 .   Tested positive on 3/18/21.  NOT hospitalized.
rash appeared in my hand again; itchy rash on my hand; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy rash on my hand) and RASH (rash appeared in my hand again) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced RASH PRURITIC (itchy rash on my hand). On 23-Mar-2021, the patient experienced RASH (rash appeared in my hand again). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. On 03-Mar-2021, RASH PRURITIC (itchy rash on my hand) had resolved. On 23-Mar-2021, RASH (rash appeared in my hand again) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history information was reported. No concomitant medication was reported.   This case was linked to MOD21-068107 (Patient Link).
601 doses were given after expiration date; 601 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (601 doses were given after expiration date) and PRODUCT STORAGE ERROR (601 doses were given after expiration date) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (601 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (601 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (601 doses were given after expiration date) and PRODUCT STORAGE ERROR (601 doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. The vaccine was placed in refrigerator on 04-Nov-2021 There was no temperature excursion. No adverse event was reported.
sugar level went up; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Jun-2021 and was forwarded to Moderna on 16-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (sugar level went up) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and 0017B12A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN for Diabetes.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced BLOOD GLUCOSE INCREASED (sugar level went up). At the time of the report, BLOOD GLUCOSE INCREASED (sugar level went up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-May-2021, Blood glucose: 9.9 (High) Patient states that blood sugar level increased after getting the second dose of Moderna vaccine.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
afib, tachycardia, heart stopped (pacemaker activated).  Lasted two and one-half weeks.
About an hour after my shot I got a slight stiffness in my neck and was hit with a sever headache with nausea and vomiting.  The headache came and went suddenly for the next several hours it was a sharp piercing headache.  The next morning I woke up with complete body aches like you would normally get with the flu.
indication=Treatment of COVID-19; indication=Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Bronchiectasis" (unspecified if ongoing); "other pulmonary issues, heart disease" (unspecified if ongoing); "allergies: Peanuts" (unspecified if ongoing); "allergies: dogs" (unspecified if ongoing); "allergies: feathers" (unspecified if ongoing); "allergies: dust" (unspecified if ongoing); "allergies: pollen" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Flexril, reaction(s): "Allergy". Vaccination history included: Covid-19 vaccine (Dose 1, unknown manufacturer), for Covid-19 Immunization; Covid-19 vaccine (Dose 2, unknown manufacturer), for Covid-19 Immunization; Covid-19 vaccine (Dose 3, unknown manufacturer), for Covid-19 Immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "indication=Treatment of COVID-19".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The next day after injection hives appeared. They last between 5-30 minutes. When they start to break they are in red itchy like the ones I get when I in-jest chocolate which I?m allergic too. They appear sporadically first on the left arm where I received the vaccine and my stomach. Today 01/16/2021 they appeared on my face, Upper back,  chest and legs.
Severe pain and swelling in right side of face from top of cheek down to under jaw.  Treated with prednisone, antibiotics, pain meds.  6 weeks later, exact same problem on opposite side of face. same treatment.
About 1 and a half hour, after vaccination patient got a rash on the left side of his face with hives. Dr. examined patient then recommended they give the child children's BENADRYL. When called later that day mom said the rash was not gone, but better. On 3/30/17 Mom called to report the rash comes back when the BENADRYL wears off.
pain at injection site; swelling; fatigue; vaccine administered after nonviable temperature excursion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 66-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 21-OCT-2023, the patient received Arexvy (intramuscular). In OCT-2023, an unknown time after receiving Arexvy, the patient experienced injection site pain (Verbatim: pain at injection site), swelling (Verbatim: swelling) and fatigue (Verbatim: fatigue). On an unknown date, the patient experienced incorrect storage of drug (Verbatim: vaccine administered after nonviable temperature excursion). In OCT-2023, the outcome of the injection site pain, swelling and fatigue were resolved. The outcome of the incorrect storage of drug was unknown.   It was unknown if the reporter considered the injection site pain, swelling and fatigue to be related to Arexvy.     It was unknown if the company considered the injection site pain, swelling and fatigue to be related to Arexvy.   Additional Information: GSK receipt date: 25-OCT-2023 The pharmacist reported that a patient received a dose of Arexvy that was found not viable after temperature excursion, which led to incorrect storage of drug. The patient had experienced swelling, pain at injection site, and fatigue.  The reporter did not know exactly when the symptoms developed or resolved and did not have the lot or expiry date. The symptoms had resolved.  The reporter did not consent to follow-up. The case had been linked to the case US2023147952, reported by the same reporter.; Sender's Comments:  US-GSK-US2023147952:1 of 2 report